H11 (NovoMAb-G2): Began Phase I/II trial

Viventia Biotech Inc. (TSE:VBI), Toronto, Ontario
Product:

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE